1999
DOI: 10.1002/(sici)1096-9926(199905)59:5<331::aid-tera4>3.0.co;2-l
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of select folate pathway genes,PAX3, and humanT in a midwestern neural tube defect population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1999
1999
2009
2009

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 87 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…Association studies of other candidate genes, such as folate receptor alpha and beta, have not been reported for human pregnancies exposed to AEDs. While differential expression of their equivalents in preclinical models has been postulated to account for some of the varying susceptibility to valproate teratogenicity (Finnell et al 1997), no evidence for an association with neural tube defects has been noted in non‐AED‐exposed populations (Trembath et al 1999). Furthermore, periconceptional supplementation with folic acid for human pregnancies exposed to AEDs does not seem to reduce the risk of other birth defects associated with folate deficiency (Hernandez‐Diaz et al 2000).…”
Section: What Can We Tell Patients Using Genetic Information?mentioning
confidence: 99%
“…Association studies of other candidate genes, such as folate receptor alpha and beta, have not been reported for human pregnancies exposed to AEDs. While differential expression of their equivalents in preclinical models has been postulated to account for some of the varying susceptibility to valproate teratogenicity (Finnell et al 1997), no evidence for an association with neural tube defects has been noted in non‐AED‐exposed populations (Trembath et al 1999). Furthermore, periconceptional supplementation with folic acid for human pregnancies exposed to AEDs does not seem to reduce the risk of other birth defects associated with folate deficiency (Hernandez‐Diaz et al 2000).…”
Section: What Can We Tell Patients Using Genetic Information?mentioning
confidence: 99%